A unique systems pharmacology platform powered by AI to accelerate drug discovery. Uses disruptive AI technology to accelerate the entire drug discovery process by identifying promising candidates, de-risking the opportunities through preclinical validations, and progressing drug candidates to the clinic through industry and investor partnerships
| Status | Active |
| Website | http://www.aivivo.co/ |
| Category | AI |
| Modality | Digital |
| Headquarters | Cambridge, UK |
| Investment Portfolio | Fund Investment |
| Co-Investors | Business Angels, Undisclosed USA Fund |